Topics to be covered at the workshop:

1. Resveratrol and cancer prevention
2. Resveratrol and physical activity
3. Resveratrol and diabetes prevention
4. Resveratrol and bone structure
5. Resveratrol and inflammation
6. Resveratrol and inflammation in obese humans
7. And other forthcoming topics

The programme includes an opportunity for the press to meet the speakers, and a Science Dating session, for project brainstorming and partnering among all participants.

Speakers to date:

• Young-Joon Surh, Seoul National University, South Korea
  • Resveratrol and cancer prevention
• Helle Buchard Boyd, DHI, DK
• Requirements for obtaining approval of health claims
• Clifton A. Baile, University of Georgia, USA
  • Resveratrol and diabetes prevention
• Angela Lee Tsetsis, Fluxome, Denmark
  • To be announced
• Joseph A. Baur, University of Pennsylvania School of Medicine, USA
  • Resveratrol and inflammation
• Siv Ahrné, Lund University, SE
  • Resveratrol and cancer
• Insa Ernst, Christian-Albrechts University, Kiel, Germany
  • Polyphenols and health modulation
• Kasia Kupisiewicz, University of Southern Denmark, DK
  • Resveratrol and cell proliferation
• Steen Bønløkke Pedersen, Aarhus University, DK
  • Resveratrol and inflammation in obese humans
• Ole Vang, Roskilde University, DK
  • Resveratrol and inflammation
• Henriette Pilegård, University of Copenhagen, DK
  • Resveratrol and physical activity

To top 

Online Registration is now closed. If you with to register after the deadline, please contact David Featherston by email.

The workshop is free to attend; lunch and networking are included.

For more information, please contact one of the following:

• Scientific topics - Prof. Ole Vang
• PhD course - Prof. Ole Vang
• Organization - David Featherston
• Sponsors - Sami Sassi

To top 

Human diet based on fruit and vegetables contains various bioactive components, which are suggested to have health-promoting effects. The claims of health-promoting effects are mostly based on animal and in vitro studies whereas the human exposure studies are mostly lacking. On the list of these bioactive compounds both resveratrol and curcumin are outstanding as the first human exposure studies have been published in the last 1-2 years.

Both resveratrol and curcumin have received much attention in the last ten years, both in scientific research and the public eye. In Denmark, a few research groups have investigated the effect of resveratrol and curcumin in different experimental models or are currently running such projects. Recently, the LIRMOI project (www.LIRMOI.com) has been initiated to evaluate the effect of resveratrol on inflammatory response in obese people.

The first international conference with focus on resveratrol (Resveratrol2010) was held in September, 2010, in Denmark. At this conference a working group formulated several recommendations on the use of resveratrol, and these recommendations were published in PLOS One. The second international conference, Resveratrol2012, is planned to be held in Leicester, December 5th – 7th 2012.

Further, there is an increasing interest from companies to include bioactive compounds in human diet and to claim a health-promoting effect from these added compounds, which presupposes human studies showing their effects. Therefore, with resveratrol and curcumin as frontrunners, we may learn from these compounds when companies want to include other bioactive compounds in human dietary products in the future.

To top